from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2918c/glnD

LFCtreatmentdescriptionclass of inhibitor

0.126

Amikacinug/mL Amikacintranslation

0.902

Cap5-10ug/mL Capreomycintranslation

2.073

Rox10-50 ug/mL Roxithromycintranslation

-0.151

SM2-5 ug/mL Streptomycintranslation

-0.034

Tet5-10 ug/mL Tetracyclinetranslation

0.273

Rif0.2-5ug/mL Rifampicintranscription

-0.207

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.483

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.761

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.107

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.193

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.417

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.203

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.363

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.352

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.151

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.122

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.594

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.790

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.399

KCN5-20 ug/mL Potassium cyaniderespiration

-0.109

NaN30.2-2 mM Sodium aziderespiration

-0.037

Nigericin50 uM Nigericinrespiration

-0.063

TRC10-150 ug/mL Triclosanrespiration

-0.059

TRZ10-25 ug/mL Thioridazinerespiration

1.340

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.906

menadione6-10 ug/mL Menadionerespiration

-0.308

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.351

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.260

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.577

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.714

NRP_1Non-replicating persistence stage 1dosRassociated

-0.091

Amp0.2mg/mL AmpicillincellWall

-0.555

Cephalexin20-100 ug/mL CephalexincellWall

-0.099

Cerulenin0.32-5 ug/mL CerulenincellWall

0.098

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.158

EMB10-20 ug/mL EthambutolcellWall

-0.307

Eta12-40 ug/mL EthionamidecellWall

-0.126

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.215

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.788

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.682

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.133

BZA0.12 mg/mL BenzamidearomaticAmides

-0.213

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.263

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.235

H2O24 mM hydrogen peroxideDNAdamaging

-0.442

Levo10 ug/mL LevofloxacinDNAdamaging

-0.437

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.697

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.172

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.017

UVUV-irradiationDNAdamaging

-0.621

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.561

Antimycin12.5-50 ug/mL Antimycin A?

-0.348

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.818

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.707

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.806

PA8240.2-2 ug/mL PA-824?

0.918

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.487

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.118

Verapamil50 uM Verapamil?

-0.214

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.652

methoxatin10-20 ug/mL Methoxatin?